Tuesday, March 03, 2015 12:46:35 AM
General Information
Event: ENDO 2015
Event Dates: Thursday, March 5, 2015 - Saturday, March 7, 2015
Floor Plan: View Exhibitors Per Search ( http://iebms.heiexpo.com/iebms/oep/oep_p5_floorplan.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&like=O ) | View This Exhibitor Only ( http://iebms.heiexpo.com/iebms/oep/oep_p5_floorplan.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&like=O&ordernbr=449 )
My Exhibitor List: View | Add This Exhibitor
Searching On: Like - O
Exhibitor
Below you will find information found for selected exhibitor.
Name: OPKO Biologics Ltd.
Address: Nes Ziona Israel
Booth: 1354 ( http://iebms.heiexpo.com/iebms/oep/oep_p2_details.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&boothnbr=1354&like=O )
Web: http://www.prolor-biotech.com ( http://www.opkorenal.com/ )
Company Description:
OPKO Health, is a multi-national pharmaceutical and diagnostics company establishing industry-leading positions in rapidly growing markets by leveraging our discovery, commercialization expertise and novel and proprietary technologies which include long acting hGH .OPKO has an ongoing phase 3 and an advance phase 2 in growth deficient adults and pediatric population.
Products/Services: Pharmaceutical Company
ENDO 2015: The 97th Annual Meeting & Expo, taking place in San Diego, CA on March 5-8, 2015, is an unique opportunity for journalists to learn about the latest research in fields as diverse as obesity, endocrine-disrupting chemicals, diabetes, testosterone, infertility, menopause, thyroid conditions, and much more. For public information officers, ENDO 2015 provides a worldwide stage to promote your institution's research to reporters through news releases and participation by your scientists in news conferences.
Designed to enhance your knowledge and skills in endocrinology, ENDO 2015 will feature a mix of programs for both the clinician and researcher. Discover the latest advances in hormone research and clinical endocrinology at ENDO 2015. The world’s largest endocrinology meeting will feature a cutting-edge scientific program, presented by leaders in the field.
Recent OPK News
- OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 09:02:37 PM
- AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • GlobeNewswire Inc. • 03/05/2024 01:52:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 09:05:23 PM
- NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st • PR Newswire (US) • 02/28/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:54 PM
- OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/16/2024 09:53:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:07:24 PM
- NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China • PR Newswire (US) • 02/05/2024 01:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 08:30:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:56:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:09:07 PM
- OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes • GlobeNewswire Inc. • 01/09/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:10:34 PM
- OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:26:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 06:39:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM